AIFF Overview

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).

Wall Street analysts forecast AIFF stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AIFF is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Firefly Neuroscience Inc revenue for the last quarter amounts to 388.00K USD, increased 1075.76

Firefly Neuroscience Inc. EPS for the last quarter amounts to -0.20 USD, decreased -67.21

Firefly Neuroscience Inc (AIFF) has 13 emplpoyees as of March 25 2026.

Today AIFF has the market capitalization of 25.87M USD.